Dupuytren’s disease market is expected to gain market growth in the forecast period of 2022-2029. Data Bridge Market Research analyses the market to account to grow at a CAGR of 4.60% in the above mentioned forecast period.
Dupuytren’s disease is a malformation of the hand that often develops over time. A layer of tissue beneath the skin of your palm is affected by the illness. The fingers become permanently bent in a flexed position in severe cases. The ring finger is the most commonly affected by Dupuytren’s contracture, followed by the little and middle fingers. Alcoholism, smoking, thyroid disorders, liver disease, diabetes, past hand injuries, epilepsy, and family history are all risk factors for Dupuytren’s contracture. This condition is also termed as Dupuytren’s contracture, familial palmar fibromatosis, and contraction of palmar fascia.
Request For a Sample Copy of This Report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-dupuytrens-disease-market
The rise in the prevalence of Dupuytren’s disease will act as major market driver and further enhance the market’s growth rate. Another significant factor influencing the growth rate of Dupuytren’s disease market is the rising healthcare expenditure. Furthermore, advancement in the medical technology, rising initiatives by public and private organisations to spread awareness about disease and growing government funding are the factors that will expand the Dupuytren’s disease market. Other factors such as rising incidences of diabetes and growing geriatric population will positively impact the Dupuytren’s disease market’s growth rate.
Moreover, the rise in the research and development activities and emerging new market will provide beneficial opportunities for the Dupuytren’s disease market in the forecast period of 2022-2029. Also, high unmet need of current treatment and developments in healthcare technology will escalate the growth rate Dupuytren’s disease market in future.
North America dominates the Dupuytren’s disease market due to the presence of major key players and high prevalence rate in this region. Additionally, growing geriatric population and well-developed healthcare infrastructure are the major drivers that will flourish the growth rate of Dupuytren’s disease market in this region. Asia-Pacific is expected to grow during the forecast period of 2022-2029 due to the increasing patient pool, rising investment in the healthcare sector, and growing government support.
Some of the major players operating in the Dupuytren’s disease market are Merck & Co., Inc., Fresenius Kabi AG, Bristol-Myers Squibb Company, Endo International plc, Pfizer Inc., Hikma Pharmaceuticals PLC, Spear Pharmaceuticals., Actiza Pharmaceutical Private Limited, Nantong Jinghua Pharmaceutical Co., Ltd., GlaxoSmithKline plc, Abbott, Bayer AG, AstraZeneca, Johnson & Johnson Private Limited, Cipla Inc., LEO Pharma A/S, Sumitomo Dainippon Pharma Co., Ltd., Novartis AG, Sanofi, Aurobindo Pharma, and Lupin, among others.
About Data Bridge Market Research:
An absolute way to forecast what future holds is to comprehend the trend today!
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.
Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475